Impact of community-based chronic obstructive pulmonary disease service, a multidisciplinary intervention in an area of high deprivation: A longitudinal matched controlled study by Saini, P et al.
 Saini, P, Rose, T, Downing, J, Mahata, B, Pilsworth, S, Pemberton, A, 
Comerford, T, Wilson, K, Shaw, M, Harper, L, Daras, K and Barr, B
 Impact of community-based chronic obstructive pulmonary disease service, a 
multidisciplinary intervention in an area of high deprivation: A longitudinal 
matched controlled study
http://researchonline.ljmu.ac.uk/id/eprint/12335/
Article
LJMU has developed LJMU Research Online for users to access the research output of the 
University more effectively. Copyright © and Moral Rights for the papers on this site are retained by 
the individual authors and/or other copyright owners. Users may download and/or print one copy of 
any article(s) in LJMU Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities or 
any commercial gain.
The version presented here may differ from the published version or from the version of the record. 
Please see the repository URL above for details on accessing the published version and note that 
access may require a subscription. 
For more information please contact researchonline@ljmu.ac.uk
http://researchonline.ljmu.ac.uk/
Citation (please note it is advisable to refer to the publisher’s version if you 
intend to cite from this work) 
Saini, P, Rose, T, Downing, J, Mahata, B, Pilsworth, S, Pemberton, A, 
Comerford, T, Wilson, K, Shaw, M, Harper, L, Daras, K and Barr, B Impact of 
community-based chronic obstructive pulmonary disease service, a 
multidisciplinary intervention in an area of high deprivation: A longitudinal 
LJMU Research Online
http://researchonline.ljmu.ac.uk/
1 
 
Title: Impact of community-based chronic obstructive pulmonary disease service, a 1 
multidisciplinary intervention in an area of high deprivation: A longitudinal matched 2 
controlled study 3 
 4 
Authors: Pooja Saini, Senior Lecturer*‡1, Tanith C. Rose, Research Associate in Health Data 5 
Analysis‡2, Jennifer Downing, NIHR CLAHRC NWC Theme Research Manager2, Bashir 6 
Matata, Head of Clinical Trial Unit3, Samantha Pilsworth, Consultant Physiotherapist3, Allan 7 
Pemberton, Public Advisor4, Terence Comerford, Publc Advisor4, Keith Wilson, Public 8 
Advisor4, Matthew Shaw, Senior Clinical Information Analyst3, Lesley M Harper, Senior 9 
Research Fellow2, Konstantinos Daras, Geographic Data Scientist2, Benjamin Barr, Senior 10 
Clinical Lecturer2. 11 
 12 
‡ Joint first authors 13 
*Corresponding author 14 
 15 
Affiliations: 1. Liverpool John Moores University, 2. University of Liverpool, 3. Liverpool 16 
Heart and Chest hospital NHS Trust, 4. NIHR CLAHRC NWC Public Advisor 17 
 18 
Corresponding author contact information: 19 
Dr Pooja Saini, School of Natural Sciences and Psychology, Tom Reilly Building, Liverpool 20 
John Moores University, Byrom Street, Liverpool, L3 3AF Email: P.Saini@ljmu.ac.uk 21 
 22 
Keywords: COPD, Respiratory, Pulmonary Rehabilitation, Re-admission, A&E attendance, 23 
Community Care Multidisciplinary  24 
 25 
2 
 
Manuscript word count: 4811 26 
Abstract word count: 197 27 
Number of references: 45  28 
3 
 
ABSTRACT 29 
Objective: To examine the effects of a consultant-led, community-based chronic obstructive 30 
pulmonary disease (COPD) service, based in a highly deprived area on emergency hospital 31 
admissions. 32 
Design: A longitudinal matched controlled study using difference-in-differences analysis to 33 
compare the change in outcomes in the intervention population to a matched comparison 34 
population, five years before and after implementation. 35 
Setting: A deprived district in the North West of England between 2005 and 2016. 36 
Intervention: A community-based, consultant-led COPD service providing diagnostics, 37 
treatment and rehabilitation from 2011–2016. 38 
Main outcome measures: Emergency hospital admissions, length of stay per emergency 39 
admission, and emergency re-admissions for COPD.  40 
Results:  The intervention was associated with 24 fewer emergency COPD admissions per 41 
100,000 population per year (95%CI -10.6 to 58.8, p=0.17) in the post-intervention period, 42 
relative to the control group. There were significantly fewer emergency admissions in 43 
populations with medium levels of deprivation (64 per 100,000 per year; 95%CI 1.8 to 126.9) 44 
and amongst men (60 per 100,000 per year; 95%CI 12.3 to 107.3).  45 
Conclusion: We found limited evidence that the service reduced emergency hospital 46 
admissions, after an initial decline the effect was not sustained. The service, however, may 47 
have been more effective in some subgroups.  48 
Keywords: Chronic Obstructive Pulmonary Disease, Respiratory Disease, Hospital 49 
Admissions, Pulmonary Rehabilitation 50 
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 51 
Strengths and limitations of this study 52 
 Within this study, we calculated the Knowsley chronic obstructive pulmonary disease 53 
(KCOPD) service in its real-life implementation setting, which makes our findings 54 
potentially more externally valid than those set in a trial context.  55 
 The KCOPD service has been in operation for several years giving a long follow-up 56 
period of five years; thus allowing us to look at whether effects were sustained.  57 
 For this study, we applied a combination of quasi-experimental methods – propensity 58 
score matching and difference-in-differences, which provide causal estimates of the 59 
intervention if the trends in outcomes would have been parallel in the absence of the 60 
intervention.  61 
 We were only able to assess the impact of the intervention of emergency hospital 62 
admissions and this may not reflect health benefits to the users of these services.  63 
 The ecological nature of this study limits the conclusions that can be drawn about 64 
individual-level factors, and the results reflect the population-level impact of the 65 
KCOPD service.   66 
  67 
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BACKGROUND 68 
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death, hospital 69 
re-admission and cost to society in the UK, responsible for 5% of all deaths, and a third of all 70 
deaths when including lung disease.1,2,3 An estimated 1.2 million people are living with 71 
diagnosed COPD which is considerably more than the 835,000 estimated by the Department 72 
of Health in 2011.1,4  The burden of COPD disproportionally effects disadvantaged 73 
socioeconomic groups with rates in the most deprived areas of the population twice as high as 74 
in the least deprived.5,6,7 The prevalence of COPD has increased by 27% over the last decade4 75 
and the burden on health services is increasing as the population ages. The costs of COPD to 76 
the National Health Service [NHS] in England is over £800 million, with an additional £3.8 77 
billion in lost productivity, and is estimated to increase annually. These costs to the NHS are 78 
unsustainable. Improving the identification and treatment of COPD, whilst reducing 79 
emergency admissions and length of inpatient stay, has been highlighted as a priority for the 80 
NHS in its Five-Year Forward View.8 The NHS Long Term Plan9 also aims to tackle health 81 
inequalities between the most and least deprived, and highlights that cause of death from 82 
respiratory diseases is the second largest contributor to the life expectancy gap between these 83 
groups. There is, therefore an urgent need for evidence of effective interventions that improve 84 
the management of COPD and reduce unplanned emergency admissions, particularly in 85 
disadvantaged populations. 86 
 87 
COPD may be preventable by avoidance or early cessation of smoking, particularly within 88 
deprived communities where there is a higher prevalence of smoking.10 However, access to 89 
smoking cessation services has reduced in recent years; only a quarter of COPD patients 90 
admitted to hospital were asked about their smoking status and subsequently offered the 91 
service.3 Existing evidence shows that rapid access pulmonary rehabilitation clinics provide 92 
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efficient and effective substitution to COPD clinic assessment.11,12  Yet, there are examples to 93 
indicate that secondary care-based rapid access clinics may be underutilised by older 94 
populations and those in poorer socioeconomic circumstances.13 This could potentially be due 95 
to problems with access, however  there is limited published evidence investigating the 96 
provision of rapid access clinics in community settings. Community-based pulmonary 97 
rehabilitation services have been found to improve access and reduce emergency 98 
admissions14, 15, 16 and be cost-effective.15 Community-based pulmonary rehabilitation shows 99 
that it is as effective and safe as hospital-based rehabilitation and has been associated with 100 
reduced length of hospital stay, reduced mortality rates and improved health‐related quality of 101 
life with COPD patients who recently suffered an exacerbation of COPD.11 Whilst there is 102 
some case study evidence for community-based consultant led services17, there is limited 103 
evidence for consultant-led COPD community-based clinics. Although there is evidence for 104 
multi-component approaches to reduce hospital admissions for single conditions18, there is a 105 
lack of evidence for consultant-led community-based integrated COPD services in deprived 106 
communities. 107 
 108 
To address these gaps in the evidence-base we investigated the impact on emergency hospital 109 
admissions of a consultant-led,community based ‘one-stop’ COPD service implemented in a 110 
very deprived community in the North West of England; particularly as there has been a 111 
significant proportion of undiagnosed COPD reported in this area.19 The service brought 112 
together diagnostic, treatment, management and rehabilitation services for COPD, offering a 113 
rapid response service within 13 hours that would usually be provided in secondary care. We 114 
examined the impact of this service on emergency admissions, length of inpatient stay and 115 
readmissions. 116 
 117 
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METHODS 118 
Setting 119 
The intervention was implemented between 2011 and 2016 across the district of Knowsley in 120 
the North West of England, which has a population of 148,56020 and is the second most 121 
deprived district in England based on the Indices of Multiple Deprivation.21 There is a history 122 
of industrial exposure, for example,  mining, manufacturing, shipping and dock work; 123 
however, comparisons between areas in Knowsley have shown no increase for the rate of 124 
hospital admissions where there was evidence of this exposure.22  125 
 126 
Study Design.  127 
This study was a longitudinal matched controlled study using lower super output areas 128 
(LSOA) as the unit of analysis. LSOAs are small geographical areas used by the UK’s Office 129 
for National Statistics, each typically containing a population of about 1,500 people. England 130 
is divided into just over 30,000 LSOAs. Ninety-Eight LSOAs cover the entire population of 131 
the intervention area – Knowsley. Each of these intervention LSOAs were matched with four 132 
control LSOAs located within other districts in the North West region of England, providing 133 
392 matched control LSOAs, i.e. 490 LSOAs in total.  We used propensity score matching23 134 
to ensure that these control areas had similar observed characteristics to the Knowsley LSOAs 135 
in the time period before the introduction of the intervention (2005–10).  The matching was 136 
based on the gender and age profile of the population, unemployment rate, Indices of Multiple 137 
Deprivation, COPD emergency admission rate, prevalence of COPD, smoking prevalence, 138 
proportion of COPD patients who have had their inhaler technique checked, numbers of GPs 139 
per capita serving the population and the distance to the nearest GP practice and hospital (see 140 
Table 1/Supplementary file, Appendix 1 for full details of the matching variables). The 141 
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nearest neighbour method was used for matching, which selects controls with propensity 142 
scores that are closest to that of the intervention LSOAs.24  We checked with the regional 143 
COPD network that no other similar intervention was implemented in the North West and, 144 
therefore, our control populations would not have experienced a similar intervention.  145 
 146 
We then compared the change (difference) in outcomes in the intervention population to the 147 
change (difference) in outcomes in a matched comparison population, six years before and 148 
five years after implementation. This difference-in-differences method controls for all time-149 
invariant differences between the intervention and control populations. The key assumption of 150 
difference-in-differences analysis is the parallel trends assumption. If the trend in the outcome 151 
in the intervention and control populations would have been parallel in the absence of the 152 
intervention then, the difference between the change in the outcomes between the two groups 153 
provides an unbiased estimate of the interventions effect25  (see supplementary file, Appendix 154 
2, for an outline of difference-in-differences methods. We investigate this assumption by 155 
testing for parallel trends between the two groups prior to the intervention (see below). 156 
 157 
Data sources and measures 158 
We used anonymised Hospital Episode Statistics (HES) and Office for National Statistics 159 
(ONS) population estimates to derive our primary outcome COPD (ICD-10 codes: J40–J44) 160 
emergency hospital admissions per 100,000 population for each of the 490 LSOAs between 161 
2005 and 2016, giving a total sample size of 5,880 LSOA-years.26,27  We chose to investigate 162 
COPD specific admissions, since all-cause admissions would likely be affected by other 163 
interventions occurring concurrently in Knowsley (e.g. a CVD service intervention)28. 164 
Emergency admissions were defined as admissions that are unpredictable and occur at short 165 
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notice because of clinical need, as per the HES data dictionary.29 Secondary outcomes were 166 
length of stay per emergency admission and emergency readmission rates also derived from 167 
HES data. Readmissions were defined as emergency admissions occurring within 30 days of 168 
the last, previous discharge from hospital.30  To adjust for time varying factors that could be 169 
associated with trends in COPD emergency admission rates we controlled for the annual 170 
percent of the population aged 50+ years, the percent female, and the percent unemployed 171 
using data obtained from the ONS. 172 
(Insert Table 1 here) 173 
The service 174 
Prior to the implementation of the Knowsley COPD service (KCOPD), the Knowsley 175 
population was served by a COPD service run fromtwo local District general hospitals (DGH) 176 
and a community service. One DGH provided consultant-led clinics from the hospital and one 177 
community clinic a week; it also provided a nurse-led ESD service and oxygen service.  A 178 
separate community service provided community reviews for patients experiencing an 179 
exacerbation of COPD, it was not, however, an admission avoidance service.  These services 180 
were provided on a Monday – Friday basis only.   The pulmonary rehabilitation service was 181 
provided by a second DGH and there was no additional support for chest clearance, 182 
breathlessness management. These services were provided by different organisations and 183 
were transferred to a single provider just before KCOPD was developed in 2011.  184 
 185 
The KCOPD provided a new integrated ‘one-stop’ consultant-led service with diagnostics in 186 
the community, covering initially five different community venues, extending to seven over 187 
the course of the service and now covering six days a week and one evening session, 188 
supported by an administration hub.31 The service was designed collaboratively with public 189 
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and patient engagement, the local CCG and local NHS healthcare providers.12 The overall 190 
service consists of the following elements by a single provider that bridged primary and 191 
secondary care: 192 
 193 
 A consultant-led multi-disciplinary clinic.  Provided from initially five Primary Care 194 
resource centres – then extending to seven due to service demands. The clinics run 195 
from 10:00 – 18:00.  The clinic offers diagnosis spirometry and diagnosis and 196 
optimisation of COPD.  The clinic now provides one Saturday morning clinic a month 197 
and a weekly evening clinic which runs up until 20:00. 198 
 Rapid response service – Nurse-led service where patients experiencing an 199 
exacerbation of COPD can self-refer for assessment, via a free phone number, for 200 
initiation of acute treatment and monitoring.  The service provides a two hour 201 
response for those at risk of hospital admission, with the aim to avoid unwarranted 202 
admissions.  This service is provided 08:00 – 22:00 with an overnight on-call service 203 
seven days a week. 204 
 Early supported discharge-patients who have been to A&E or been admitted into 205 
hospital with an exacerbation of COPD can be referred into the service for additional 206 
support to facilitate an earlier discharge from hospital.  This service is provided 08:00 207 
– 22:00 seven days a week. 208 
 Home Oxygen and Review Service (HOSAR) – The HOSAR provides assessment and 209 
review of patients’ home oxygen requirements, they review patients in the same 210 
community venues as the consultant-led clinics as well as providing home visits.  This 211 
service is provided Monday – Friday 10:00 – 18:00. 212 
 Pulmonary Rehabilitation (PR) and Physiotherapy – The PR team cover the main 213 
areas of Knowsley, for patients who have functional limitation due to the dyspnoea or 214 
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who have had a recent hospital admission due to COPD.  PR is provided five days a 215 
week 10:00 – 18:00.  The team also provides assessment and treatment for patients 216 
who have difficulty in clearing their sputum or who are struggling with managing their 217 
dyspnoea, this service is provided seven days a week 10:00 – 18:00. 218 
 Palliative Care – The KCOPD service provides assessment and review for patients 219 
who maybe entering the palliative phase of their condition to ensure effective 220 
symptom management.   221 
 Counselling service – The KCOPD service has a dedicated respiratory counsellor who 222 
offers treatment and support for patients struggling with anxiety and depression or 223 
struggling with the impact of their condition on their life.  This element of the service 224 
runs Monday – Friday 10:00 – 18:00. 225 
 226 
The service is available to residents in Knowsley through GP referral.12 Patients are seen 227 
within 10 days of referral. Once known to the service, if they have been provided with a 228 
confirmed diagnosis of COPD, they can access any element of the services at any time 229 
without being re-referred by their GP. Knowsley GP referral trends to the KCOPD data show 230 
a dramatically decreasing trend (Supplementary file, Appendix 3). From 2010/11 to 2016/17 231 
(financial year) the clinic has provided care to almost 5,500 patients.12 Clinic attendance has 232 
been variable, particularly at the outset of the service (with non-attendance as high as 20%) 233 
stabilising to around 10-12% from 2015 onwards.12 Initially the service was contracted for 234 
three years, at a total value of £4,991,667. 235 
  236 
Statistical Analysis 237 
Our sample size was predetermined based on the number of LSOAs in the intervention area 238 
and the number of matched LSOAs. Prior to our analysis,  we estimated the effect size that 239 
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the study would be able to detect with an 80% power by running multiple simulations of the 240 
planned analysis.32,33 This indicated that the effect  size for this study  at 80%  power  to  241 
detect,  was around a 10-11%  decline  in  emergency  admission rates per year associated  242 
with  the intervention (see Supplementary file, Appendix 4).  243 
Characteristics of the intervention and control populations prior to the intervention were 244 
initially compared to assess the balance achieved between the groups. Additionally, the 245 
parallel trends assumption was tested using graphical methods and regression models to 246 
compare trends in the outcomes of interest between the intervention and control populations 247 
in the pre-intervention period. 248 
 249 
To estimate the difference-in-differences, i.e. the difference between the change in outcomes 250 
before and after the intervention in the intervention population compared to the change in 251 
outcomes over the same time periods in the control population, we include a treatment by 252 
period interaction term in a linear regression model. To control for potential demographic and 253 
socioeconomic changes which may confound the result we included annual LSOA data on 254 
unemployment rates, the  percentage of the population that were female and the percentage 255 
aged 50+ years in the model. We included a trend term for time to account for the long term 256 
trend in admission rates across the intervention and comparison groups and an additional 257 
spline term to account for any change in overall trends across both groups after the 258 
intervention. In sensitivity analysis we estimated a model removing the spline term – i.e. just 259 
including an annual trend term. We also included a random intercept for each LSOA to 260 
account for the longitudinal nature of the data (see Supplementary file, Appendix 5 for full 261 
details of the statistical model). 262 
 263 
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Robustness tests 264 
We investigated the presence of unobserved confounding by repeating the analysis using an 265 
outcome that would not be expected to be influenced by the COPD intervention, i.e. 266 
emergency admissions for gastrointestinal (GI) infections. We also investigated whether the 267 
effect of the intervention was different in more deprived LSOAs compared to less deprived 268 
LSOAs within Knowsley, and whether the effect differed between men and women. Analyses 269 
were conducted using R (version 3.4.3). 270 
 271 
Patient involvement 272 
The research question was developed through a collaboration involving local health service 273 
providers, public advisors and researchers. Public advisors are members of the public and/or 274 
service users who have knowledge of KCOPD and the locality in which it is delivered. The 275 
public advisors were involved in a series of meetings agreeing the focus for the research and 276 
the planned analysis. Three of the public advisors (TC, KW and AP) are co-authors of this 277 
paper and have contributed to the drafting of the paper and the interpretation of the results.  278 
 279 
RESULTS 280 
Characteristics of the Knowsley and matched control LSOAs in the pre-intervention period 281 
(2005-10) are shown in Table 2. Although the control areas at baseline were statistically 282 
significantly different from the intervention areas on a number of characteristics, these 283 
differences are relatively small and the difference-in-differences method accounts for these 284 
fixed differences in the analysis. The control areas were all also areas with high levels of 285 
deprivation and COPD emergency admissions. This is particularly the case when compared to 286 
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the unmatched sample of North West LSOAs (see Supplementary file, Appendix 6 for 287 
characteristics of unmatched sample). 288 
(Table 2 here) 289 
Trends in COPD emergency hospital admission rates per year for the Knowsley and control 290 
population are shown in Figure 1. In the pre-intervention period, emergency admission rates 291 
were slightly higher for Knowsley compared to the control population, and parallel trends in 292 
the rates were apparent between the two groups. Following the introduction of the 293 
intervention in 2011, admission rates for Knowsley decreased to levels observed in the control 294 
population. After the second year of the intervention, however, the admission rates appeared 295 
to have increased again in Knowsley compared to the control population (also see Table 296 
3/Supplementary file, Appendix 7 for annual emergency admission rates in the two groups).  297 
(Figure 1 and Table 3 here)  298 
Results from the difference-in-differences analysis for emergency admission rates are shown 299 
in Table 4.  The coefficient for the difference-in-differences estimator indicates that on 300 
average the intervention was associated with a non-statistically significant reduction of 24 301 
emergency COPD admissions per 100,000 per year (95% CI -10.6 to 58.8, p=0.14) in 302 
Knowsley compared to the control population following the introduction of the intervention. 303 
(see Supplementary file, Appendix 8 for full model output). This was equivalent to a 5% 304 
decline in emergency admissions. We found that the intervention had no statistically 305 
significant effect on reducing length of stay per emergency COPD admissions, or emergency 306 
re-admission rates (Supplementary file, Appendix 9). 307 
Analysing the differential effects of the intervention by deprivation and by gender we found 308 
some evidence that these effects differed across these sub groups (Supplementary file, 309 
Appendix 10). The intervention had no statistically significant effect on emergency 310 
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admissions in populations with low (Table 5) and high (Table 6) levels of income deprivation. 311 
Although there was some evidence to suggest that the intervention was associated with 64 312 
fewer emergency admissions per 100,000 per year (95% CI 1.8 to 126.9 [p=0.044]) for 313 
populations with medium levels of income deprivation (Table 7). Furthermore, for men the 314 
intervention was associated with a reduction of 60 admissions per 100,000 per year (95% CI 315 
12.3 to 107.3 [p=0.014]; Table 8), but there were no statistically significant effect for women 316 
(Table 9).  317 
 (Table 4 here) 318 
(Tables 5, 6, 7 here) 319 
(Tables 8, 9 here) 320 
Robustness tests 321 
We found that during the pre-intervention period there was no significant difference in trends 322 
in emergency admission rates between Knowsley and the control population (Supplementary 323 
file, Appendix 11), suggesting that the parallel trend assumption was not violated in this 324 
analysis. We found that there was no effect when running the analysis using an outcome 325 
(emergency admissions for GI infections) that would not plausibly be influenced by the 326 
intervention but could have been influenced by unobserved confounding (Supplementary file, 327 
Appendix 11). Estimating a model removing a spline term allowing for a change in trend 328 
across both groups after the intervention did not change the results (Supplementary file, 329 
Appendix 11). 330 
 331 
DISCUSSION 332 
Principle findings 333 
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We found that an integrated, consultant-led, multi-component, community-based service was 334 
associated with a small decline in emergency admissions for COPD, however, this is not 335 
statistically significant at the 5% level. Subgroup analysis indicated that the intervention may 336 
have been effective at reducing emergency admissions for men, and for people living within 337 
neighbourhoods that were of intermediate levels of deprivation for Knowsley.   338 
 339 
Strengths and limitations 340 
Our study has a number of strengths. Firstly, we calculated the KCOPD in its real-life 341 
implementation setting, which makes our findings potentially more externally valid than those 342 
set in a trial context. Secondly, the service has been in operation for several years giving a 343 
long follow-up period of five years. This allowed us to look at whether effects were sustained. 344 
Thirdly, we applied a combination of quasi-experimental methods – propensity score 345 
matching and difference-in-differences, which provide causal estimates of the intervention if 346 
the trends in outcomes would have been parallel in the absence of the intervention. Our 347 
approach provides a reasonably large effective sample size of 5880 observations providing 348 
reasonable power to identify relatively small effects.  349 
 350 
However, some limitations remain. We cannot rule out the possibility that different trends in 351 
unobserved confounding factors between the two groups may have influenced the results. 352 
Although there are clear differences between the intervention and control groups, time 353 
invariant differences between the two groups could not bias the results due to the difference-354 
in-differences methods.34 The reasons for matching was to identify groups that were likely to 355 
follow a similar trend over time, which was confirmed by assessing the parallel nature of the 356 
trends in outcomes before the intervention. We additionally controlled for a number of 357 
observed confounders. Unobserved confounders therefore could only bias the results if they 358 
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followed different time trends over time between the intervention and control groups. When 359 
repeating the analysis using an outcome that would not plausibly be influenced by the 360 
intervention (emergency admissions for GI infections) but could have been influenced by 361 
unobserved confounding, such as changes health service admission thresholds or health 362 
provider financial incentives, we found no significant effect of the intervention. We did not 363 
have access to data on other outcomes such as use of domiciliary oxygen, oral corticosteroids 364 
or out of hours calls, and were only able to assess the impact of the intervention on emergency 365 
COPD  hospital admissions, length of stay and emergency COPD readmission rates. Whilst 366 
these outcomes may not fully reflect health benefits to the users of these services, they were 367 
the planned outcomes of the intervention agreed by the commissioner in their contract with 368 
the service provider. Finally, the ecological nature of this study limits the conclusions that can 369 
be drawn about individual-level factors, and the results reflect the population-level impact of 370 
the KCOPD.   371 
 372 
Meaning of the study: possible implications for adoption  373 
We found little evidence for an overall effect of the intervention with an initial decline 374 
in admissions not sustained throughout the follow up period. There are a number of potential 375 
reasons why we fail to find clear evidence of effectiveness. Firstly, our study was 376 
underpowered to detect a small effect. Our prior power calculations indicated that the study 377 
had sufficient power to detect a 10% decline in emergency admissions, if the effect was 378 
smaller than this the study may have failed to detect that effect. Secondly, it may have been 379 
the case that the effectiveness of the programme declined over time as is suggested in Figure 380 
1. This may be because as the service reached full capacity it was less able to fully 381 
accommodate patient needs. This was supported by reports from the service that they had to 382 
undergo a staff reorganisation in 2012 in order to meet demand more effectively.12  This is 383 
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also supported by the trend in the rate of referrals from  GP services – which were high in the 384 
first year but then decreased rapidly from 2013 (see Appendix 3, Supplementary file). This 385 
could indicate that the service may have been effective in the initial two years as it saw people 386 
with existing COPD with unmet needs, in the following years, as only new suspected COPD 387 
patients were referred, the numbers reduced year on year.12  388 
 389 
Some COPD interventions have been found to be less effective in deprived populations.1,30 390 
However, the KCOPD we investigated varied in effectiveness across levels of deprivation as 391 
there was a greater effect on those patients from areas with medium levels of deprivation 392 
compared to high and low levels of deprivation within Knowsley. The borough of Knowsley 393 
is a very deprived area, therefore intermediate deprivation in Knowsley is still quite deprived 394 
when comparing nationally. The most deprived areas in Knowsley are within the most 395 
deprived 10% of areas nationally and are likely to include populations with multiple 396 
conditions as risk factors.35 As stated in previous research,3,9,13 and due to the high levels of 397 
deprivation in Knowsley, COPD patients  may have had greater difficulty in accessing the 398 
service, found it harder to attend appointments or may have presented late with more 399 
advanced disease. All of these factors could limit effectiveness. It is unclear why the service 400 
would have been less effective in the more affluent areas of Knowsley which have similar 401 
levels of deprivation to the national average. It may have been that lower burden of disease in 402 
these areas meant that there was less marginal benefit from the service. This indicates the 403 
importance of understanding the needs of the local population when developing similar 404 
services and the need to involve people from different population groups in their design. The 405 
recent local evaluation of the service, for example, highlighted that access and use could have 406 
been improved if services were located close to existing community services and public 407 
transport routes.12 Additionally, as there is a higher prevalence of COPD in more deprived 408 
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areas, more COPD clinics are available which results in more visits with patients. Therefore 409 
the same level of provision is provided in deprived areas but the availability of care is 410 
higher.12 However, nationally accessibility to services can be a postcode lottery as all services 411 
are commissioned differently. 412 
 413 
It is possible that a reduction in admissions could be a cohort effect related to prior industrial 414 
exposure, however this would likely lead to a more gradual decline, not the steep change we 415 
see at the intervention point. Comparisons between areas in Knowsley have shown no 416 
historic increase for the rate of hospital admissions where there was evidence of this 417 
exposure,22 suggesting that this is not leading to a decline as the exposed may have already 418 
died. Additionally, matched controls were from other deprived areas in the North West where 419 
industrial affects would be similar. 420 
 421 
The intervention also appeared to be less effective amongst women. Some potential 422 
explanations of this may have been because women  are: being diagnosed less than men as 423 
some clinicians see COPD as a ‘man’s disease’;35 being frequently under-treated for COPD;36 424 
finding it harder to quit smoking;37 and obtaining more damage to their lungs than men.38 425 
Additionally, women are less likely to access services due to having multiple caring 426 
responsibilities and less time for treating their own health.39,40 Although more men smoke 427 
(80:20%), the similar mortality rate among men and women with COPD can be explained by 428 
a rapid deterioration of women once they begin smoking and more severe COPD disease.41 429 
Women are more susceptible to developing COPD younger due to being more vulnerable to 430 
the social context of smoking. This is reflected in the rates of women smokers that has 431 
increased in recent years,1 and are notably higher within the Knowsley region.5,19 432 
Additionally, a poorer quality of life has been reported more frequently in women than in men 433 
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with COPD due to biological and genetic factors42 along with more hospitalisation.43  434 
However, the extent to which susceptibility and vulnerability contribute and interact to 435 
explain gender differences for COPD development and its severity is largely underreported.  436 
Future initiatives should therefore consider gender-specific issues, such as differential 437 
incidences of comorbid conditions, a higher risk of exacerbations and higher symptom 438 
burden. Smoking cessation management and COPD treatment should be specifically tailored 439 
to individual women and reviewed regularly to optimise patient outcomes. Furthermore, 440 
education should be an integral part of COPD for women, as it may help to empower them to 441 
take control of their disease. 442 
 443 
The evidence for recent integration initiatives in the UK has tended to rely on evaluations that 444 
have not used quasi-experimental or experimental designs; thus providing limited evidence of 445 
impact.44,45 Our findings indicate that the KCOPD model of out of hospital treatment for 446 
COPD may have had limited or no impact on overall emergency admission rates, although it 447 
may have been more effective for some population groups. This appears to have been because 448 
effects were not sustained over the long term. This highlights the importance of designing out 449 
of hospital services so they address the different needs of particular population segments and 450 
are sufficiently resourced to sustain access over the long term.  451 
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Figure 1. Trends in COPD emergency hospital admission rates per year, by Knowsley and 642 
matched control LSOAs, 2005–16 643 
 644 
Table 1.  Description of matching variables 645 
The following variables were included in a propensity score model to match Knowsley to 646 
control areas in the time period before the introduction of the intervention (2005–10).   647 
Matching variable Details 
Age and gender profile of 
the population 
Annual data on the size of the female population and the 
population aged 50+ years per lower super output area 
(LSOA) were derived from mid-year population estimates 
provided by the Office for National Statistics (ONS). 
Unemployment rate Annual unemployment rates were calculated using 
claimant data provided by the ONS. Unemployment was 
measured as the proportion of people aged 16–64 years 
claiming Jobseeker’s Allowance or Universal Credit 
principally for the reason of being unemployed.  
Chronic obstructive 
pulmonary disease 
(COPD) emergency 
admission rate 
Emergency admissions for COPD were defined using 
ICD-10 codes: J40–J44. Annual COPD emergency 
admission rates per 100,000 population were calculated 
using Hospital Episode Statistics (HES), with population 
data obtained from the ONS. Continuous inpatient (CIP) 
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spells were used to calculate emergency admissions per 
calendar year.  
Indices of Multiple 
Deprivation 
Index of Multiple Deprivation 2015 data were provided 
by the Department for Communities and Local 
Government. 
Quality and Outcomes 
Framework (QOF) 
indicators  
QOF indicator data for the prevalence of COPD and 
smoking, and the percentage of patients with COPD 
receiving inhaled treatment whose inhaler technique had 
been checked within the previous 15 months were 
included in the propensity score model. Weighted 
averages of QOF indicators per LSOA were calculated 
using data provided by NHS Digital on the number of 
patients registered per general practice per LSOA. 
Numbers of general 
practitioners (GPs) per 
capita serving the 
population 
Weighted averages of the number of full-time employed 
GPs per 1000 population were calculated using data 
provided by NHS Digital on the number of GPs and 
patients registered per general practice per LSOA. 
Distance to the nearest 
general practice and 
hospital 
The Consumer Data Research Centre provided data per 
LSOA on the average road network distance to the 
nearest hospital with an Accident and Emergency (A&E) 
department, and the nearest general practice. Road 
network distances in kilometres were calculated by 
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deriving the fastest route by car to travel from each 
postcode within an LSOA to the nearest health service. 
 
 648 
Table 2. Characteristics of Knowsley and matched control LSOAs in pre-intervention 649 
period (2005–10) 650 
 
Knowsley LSOAs 
(number = 98) 
Control LSOAs 
(number = 392) 
 
 
mean (SD) mean (SD) p-valuea 
IMD score 41.99 (20.65) 37.96 (21.35) <0.001 
Distance to hospital with A&E 
(km) 
5.47 (2.5) 5.36 (2.84) 0.401 
Working age population 
unemployed (%)  
4.99 (2.76) 4.54 (2.97) 0.001 
GPs per 1000 population  0.64 (0.12) 0.63 (0.13) 0.002 
Population (number)  1508.79 (244.92) 1496.45 (246.56) 0.702 
Female population (number)   792.08 (129.75) 779.55 (129.69) 0.032 
Population aged 50+ years 
(number)  
496.81 (109.49) 499.59 (119.93) 0.610 
QOF: COPD prevalence (%)   3.07 (0.33) 2.84 (0.63) <0.001 
QOF: smoking prevalence (%)  25.83 (4.77) 24.82 (5.45) <0.001 
QOF: those with COPD receiving 
inhaled treatment whose inhaler 
technique has been checked (%)  
88.13 (9.21) 89.06 (5.06) <0.001 
Emergency admissions for COPD 
per 100,000 population per year  
519.99 (402.33) 468.46 (389.75) 0.004 
a statistical significance of the difference between the groups tested using t-tests for 
normally distributed variables, or the Man-Whitney U test as a nonparametric equivalent  
A&E = Accident and Emergency department; COPD = Chronic Obstructive Pulmonary 
Disease; GP = general practitioner; IMD = Index of Multiple Deprivation; km = kilometres; 
LSOA = Lower-layer Super Output Area; QOF = Quality and Outcomes Framework; SD = 
standard deviation 
 
 651 
 652 
 653 
29 
 
 654 
 655 
 656 
Table 3. Emergency admission rates for COPD per 100,000 population per year 657 
 658  
Knowsley LSOAs (number = 98)  Control LSOAs (number = 392) 
Year Mean 
Lower 
95% CI 
Upper 
95% CI 
Mean 
Lower 
95% CI 
Upper 
95% CI 
2005 542.6 467.2 618.1  491.5 450.4 532.5  
2006 563.2 467.4 659.1  491.1 449.8 532.5  
2007 545.9 464.7 627.2  502.6 461.5 543.7  
2008 473.5 402.2 544.9  464.4 426.9 501.9  
2009 463.7 389.6 537.9  408.3 374.4 442.2  
2010 469.3 394.4 544.2  426.2 390.8 461.6  
2011 397.5 338.9 456.1  392.2 358.7 425.7  
2012 405.0 343.4 466.6  396.2 364.4 428.0  
2013 394.3 333.3 455.2  402.3 369.3 435.4  
2014 484.9 417.3 552.6  428.5 392.8 464.2  
2015 455.1 385.6 524.6  429.0 392.6 465.4  
2016 500.3 421.3 579.3 442.2 407.0 477.4 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; LSOA = 
Lower-layer Super Output Area 
 
 659 
 660 
 661 
 662 
 663 
Table 4. Result of difference-in-differences analysis showing the change in COPD emergency 664 
admissions per 100,000 population in Knowsley following the intervention relative to the control 665 
group,, 2005–16 666 
 667  
Coefficient Lower 95% 
CI 
Upper 95% 
CI 
p-
value 
Treatment (Knowsley = 1; control = 0) 37.99 -14.39 90.37 0.155 
Period (post-intervention = 1; pre-
intervention = 0) -20.03 -49.18 9.12 0.178 
DiD estimator (treatment*period) -24.10 -58.79 10.59 0.173 
Model based on equation shown in Supplementary file and includes random  intercept for 
LSOA, and fixed effects for percent of population aged 50+ years, percent female, percent 
unemployed and two spline terms for time (full model results are given in Supplementary file).  
Model based on 98 Knowsley and 392 control LSOAs, and 5880 observations 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; DiD = Difference-
in-Differences; LSOA = Lower-layer Super Output Area 
 
 668 
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Table 5. Result of difference-in-differences analysis showing the change in COPD emergency 669 
admissions per 100,000 population in Knowsley following the intervention relative to the control 670 
group, for areas with low income deprivation, 2005–16 671 
 672  
Coefficient Lower 95% 
CI 
Upper 95% 
CI 
p-
value 
Treatment (Knowsley = 1; control = 0) -15.78 -65.11 33.54 0.528 
Period (post-intervention = 1; pre-
intervention = 0) -25.70 -57.65 6.25 0.115 
DiD estimator (treatment*period) 29.99 -9.88 69.86 0.140 
Model includes random  intercept for LSOA, and fixed effects for percent of population aged 
50+ years, percent female, percent unemployed and two spline terms for time (full model 
results are given in Supplementary file).  
Model based on 29 Knowsley and 135 control LSOAs, and 1968 observations 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; DiD = Difference-
in-Differences; LSOA = Lower-layer Super Output Area 
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Table 6. Result of difference-in-differences analysis showing the change in COPD emergency 680 
admissions per 100,000 population in Knowsley following the intervention relative to the control 681 
group, for areas with high income deprivation, 2005–16 682 
 
Coefficient Lower 95% 
CI 
Upper 95% 
CI 
p-
value 
Treatment (Knowsley = 1; control = 0) 43.22 -36.52 122.95 0.286 
Period (post-intervention = 1; pre-
intervention = 0) -50.36 -112.14 11.41 0.110 
DiD estimator (treatment*period) -49.57 -119.48 20.33 0.164 
Model includes random  intercept for LSOA, and fixed effects for percent of population aged 
50+ years, percent female, percent unemployed and two spline terms for time (full model 
results are given in Supplementary file).  
Model based on 37 Knowsley and 125 control LSOAs, and 1944 observations 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; DiD = Difference-
in-Differences; LSOA = Lower-layer Super Output Area 
 683 
 684 
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Table 7. Result of difference-in-differences analysis showing the change in COPD emergency 685 
admissions per 100,000 population in Knowsley following the intervention relative to the control 686 
group, for areas with medium income deprivation, 2005–16 687 
 
Coefficient Lower 95% 
CI 
Upper 95% 
CI 
p-
value 
Treatment (Knowsley = 1; control = 0) 18.88 -60.48 98.25 0.639 
Period (post-intervention = 1; pre-
intervention = 0) 19.78 -32.27 71.83 0.456 
DiD estimator (treatment*period) -64.33 -126.91 -1.76 0.044 
Model includes random  intercept for LSOA, and fixed effects for percent of population aged 
50+ years, percent female, percent unemployed and two spline terms for time (full model 
results are given in Supplementary file).  
Model based on 32 Knowsley and 132 control LSOAs, and 1968 observations 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; DiD = Difference-
in-Differences; LSOA = Lower-layer Super Output Area 
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 701 
Table 8. Result of difference-in-differences analysis showing the change in COPD emergency 702 
admissions per 100,000 women in Knowsley following the intervention relative to the control 703 
group,  2005–16 704 
 705  
Coefficient Lower 95% 
CI 
Upper 95% 
CI 
p-value 
Treatment (Knowsley = 1; control = 0) 45.48 -17.81 108.77 0.159 
Period (post-intervention = 1; pre-
intervention = 0) -16.43 -57.40 24.54 0.432 
DiD estimator (treatment*period) 6.09 -42.67 54.84 0.807 
Model includes random  intercept for LSOA, and fixed effects for percent of population aged 
50+ years, percent female, percent unemployed and two spline terms for time (full model results 
are given in Supplementary file). Model based on 98 Knowsley and 392 control LSOAs, and 
5880 observations 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; DiD = Difference-
in-Differences; LSOA = Lower-layer Super Output Area 
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 708 
Table 9. Result of difference-in-differences analysis showing the change in COPD emergency 709 
admissions per 100,000 men in Knowsley following the intervention relative to the control group, 710 
2005–16 711 
 712  
Coefficient Lower 95% 
CI 
Upper 95% 
CI 
p-value 
Treatment (Knowsley = 1; control = 0) 18.50 -37.07 74.07 0.513 
Period (post-intervention = 1; pre-
intervention = 0) -22.72 -62.63 17.19 0.264 
DiD estimator (treatment*period) -59.80 -107.29 -12.32 0.014 
Model includes random  intercept for LSOA, and fixed effects for percent of population aged 
50+ years, percent female, percent unemployed and two spline terms for time (full model results 
are given in Supplementary file). Model based on 98 Knowsley and 392 control LSOAs, and 
5880 observations 
CI = confidence interval; COPD = Chronic Obstructive Pulmonary Disease; DiD = Difference-
in-Differences; LSOA = Lower-layer Super Output Area 
 713 
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